Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot study of plasma exchange with human albumin in amyotrophic lateral sclerosis
2013-004842-40Phase 4Completed
- Sponsor
- Instituto Grifols
- Start
- Mar 2014
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4 trial of albumin (human) in amyotrophic lateral sclerosis (ALS), sponsored by Instituto Grifols. Primary endpoint: Change from baseline in ALSFRS-R. Started Mar 2014; status: completed.
02
Drugs
albumin (human)
03
Conditions
amyotrophic lateral sclerosis (ALS)
Beyond the preview
Go deeper on 2013-004842-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-004842-40.